Master this deck with 20 terms through effective study methods.
Generated from text input
Diabetes mellitus is a disease characterized by high blood glucose levels due to insufficient production or activity of the hormone insulin. It can be caused by genetic factors, lifestyle choices, and other health conditions.
Type 1 diabetes is caused by the body's inability to produce insulin, often requiring insulin therapy. Type 2 diabetes is characterized by low insulin production or the body's inability to use insulin effectively, often managed through lifestyle changes and medication.
Insulin was isolated by Dr. Frederick Banting and Dr. Charles Best at the University of Toronto in 1922.
Helen Free invented a method for analyzing blood sugar levels through dip-test urinalysis, allowing individuals with diabetes to monitor their blood sugar levels easily at home.
Insulin was initially collected from the pancreases of pigs and cows, which led to allergic reactions in some patients, despite being necessary for their survival.
Genetic engineering is the intentional production of new genes and alteration of genomes. It relates to insulin production by allowing scientists to insert the human insulin gene into bacteria for mass production of human insulin.
Restriction enzymes, also known as restriction endonucleases, cut DNA at specific locations, allowing scientists to isolate DNA fragments that contain desired genes for genetic recombination.
A recognition site is a specific sequence of nucleotides on a DNA strand that is recognized and cut by a particular restriction enzyme.
Restriction enzymes cut the DNA backbone at specific recognition sites, leaving behind complementary 'sticky' ends that can easily bind with other DNA fragments.
Recombinant DNA is a DNA strand created using DNA pieces from two or more sources, formed by combining DNA fragments that have been cut by restriction enzymes.
Examples include EcoRI (recognition site: 5'-GAATTC-3'), XhoI (5'-CTCGAG-3'), HindIII (5'-AAGCTT-3'), and SmaI (5'-ACCCGGGT-3'). Each enzyme has a specific recognition site and produces sticky ends.
Understanding restriction enzymes is crucial for genetic engineering as they enable the precise cutting and manipulation of DNA, which is essential for cloning, gene therapy, and the production of genetically modified organisms.
Approximately 5% of all deaths are caused by diabetes, highlighting the disease's impact on public health and the importance of effective management and treatment strategies.
Advancements include the development of insulin analogs, continuous glucose monitoring systems, and improved methods for insulin delivery, significantly enhancing the quality of life for individuals with diabetes.
Before the discovery of insulin, doctors tested for diabetes by tasting a patient's urine. The introduction of dip-test urinalysis allowed for a more accurate and hygienic method of monitoring blood sugar levels.
Patients with type 1 diabetes face challenges such as the need for lifelong insulin therapy, the risk of hypoglycemia, and the need for constant monitoring of blood glucose levels.
Lifestyle changes such as diet modification, regular physical activity, and weight management can significantly improve insulin sensitivity and blood glucose control in individuals with type 2 diabetes.
Palindromic recognition sites allow restriction enzymes to cut both strands of DNA symmetrically, creating compatible ends for ligation and facilitating the recombination of DNA fragments.
Genetic engineering contributes to medicine by enabling the production of therapeutic proteins, development of gene therapies, and creation of genetically modified organisms for research and treatment purposes.
Ethical considerations include concerns about genetic modification, potential long-term effects on ecosystems, the implications of gene therapy, and the accessibility of genetic technologies.